3,4-dihydroxyphenylethanol has been researched along with 1-methyl-4-phenylpyridinium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eisenhofer, G; Harvey-White, J; Kirk, K; Kopin, IJ; Lamensdorf, I; Nechustan, A | 1 |
| Avila-Acevedo, JG; Garcia-Jimenez, S; Monroy-Noyola, A; Montes, S; Perez-Barron, GA; Rios, LC; Rubio-Osornio, M | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylethanol and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Dopamine; Energy Metabolism; Enzyme Inhibitors; Estrogens, Non-Steroidal; Fluorenes; Hydantoins; Isoflavones; Mitochondria; Neurons; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; PC12 Cells; Phenylethyl Alcohol; Rats; Rotenone | 2000 |
Hydroxytyrosol inhibits MAO isoforms and prevents neurotoxicity inducible by MPP+ invivo.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antioxidants; Catecholamines; Corpus Striatum; Dopamine; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Phenylethyl Alcohol; Protein Isoforms; Rats; Rats, Wistar | 2020 |